Title: Tardive Dyskinesia Awareness Week

Summary: Recognizing the week of May 5, 2024, as "Tardive Dyskinesia Awareness Week" in Florida and encouraging those experiencing uncontrollable, abnormal, and repetitive movements to consult their health care provider regarding their symptoms, etc.

Full Text:
WHEREAS, while ongoing treatment with these medications can be necessary, prolonged use is associated with tardive dyskinesia (TD), and WHEREAS, TD is an involuntary movement disorder characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, and fingers or toes, and WHEREAS, even mild symptoms of TD can impact people physically, socially, and emotionally, and WHEREAS, it is estimated that TD affects approximately 600,000 people in the United States, and approximately percent of people with TD have not been diagnosed, making it important to raise awareness about the symptoms, and WHEREAS, it is important that people taking these medications be monitored for TD by a health care provider, with regular screening for TD recommended by the American Psychiatric Association, and WHEREAS, clinical research has led to approval of treatments for adults with TD by the U.S. Food and Drug Administration, and recognition and treatment of TD can make a positive impact on the lives of many people experiencing serious mental illness or gastrointestinal disorders, and WHEREAS, it is important to raise awareness of TD among the public and the medical community, NOW, THEREFORE, Be It Resolved by the Senate of the State of Florida: That the week of May 5, 2024, is recognized as  Tardive Dyskinesia Awareness Week  in Florida, and those experiencing uncontrollable, abnormal, and repetitive movements are encouraged to consult their health care provider regarding their symptoms.